Cytoplasmic PAR-3 protein expression is associated with adverse prognostic factors in clear cell renal cell carcinoma and independently impacts survival
Dagher, Julien, MBBS, Dugay, Frédéric, PharmD, Rioux-Leclercq, Nathalie, MD, PhD, Verhoest, Gregory, MD, Oger, Emmanuel, MD, PhD, Bensalah, Karim, MD, PhD, Cabillic, Florian, PharmD, PhD, Jouan, Florence, MILT, Kammerer-Jacquet, Solene-Florence, MD, Fergelot, Patricia, MD, PhD, Vigneau, Cécile, MD, PhD, Arlot-Bonnemains, Yannick, PhD, Belaud-Rotureau, Marc-Antoine, PharmD, PhD
Published in Human pathology (01.08.2014)
Published in Human pathology (01.08.2014)
Get full text
Journal Article
Description of 2 angiogenic phenotypes in clear cell renal cell carcinoma
Edeline, Julien, MD, Mottier, Stéphanie, BSc, Vigneau, Cécile, MD, PhD, Jouan, Florence, Perrin, Christophe, MD, Zerrouki, Selim, MD, Fergelot, Patricia, MD, Patard, Jean-Jacques, MD, PhD, Rioux-Leclercq, Nathalie, MD, PhD
Published in Human pathology (01.11.2012)
Published in Human pathology (01.11.2012)
Get full text
Journal Article
Plasma level and tissue expression of vascular endothelial growth factor in renal cell carcinoma: a prospective study of 50 cases
Rioux-Leclercq, Nathalie, MD, PhD, Fergelot, Patricia, MD, PhD, Zerrouki, Salim, MD, Leray, Emmanuelle, MD, Jouan, Florence, Bellaud, Pascale, Epstein, Jonathan I., MD, Patard, Jean-Jacques, MD
Published in Human pathology (01.10.2007)
Published in Human pathology (01.10.2007)
Get full text
Journal Article